Latest Breaking News On - Cardiamp cell therapy program - Page 1 : comparemela.com

BioCardia s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

BioCardia s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United statesCarl pepinePeter altmanUniversity of wisconsin at madisonBiocardia incUniversity florida at gainesvilleCardiamp cell therapy programSteering committeeChronic myocardial ischemiaExecutive steering committeeUniversity floridaAmish ravalBreakthrough therapyIschemic heart failure

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanMiranda petoDavid mcclungCenters for medicare medicaid servicesBiocardia incExchange commission onCardiamp cell therapy programMaryland stem cell research fundHeart failureMedicaid servicesNew technologyAmbulatory payment classificationsFailure trialHeart failure therapeuticsChief executive

BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes

SUNNYVALE, Calif., Dec. 18, 2023 BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced.

United statesMiranda petoDavid mcclungPeter altmanDevice agencyMedicaid servicesCardiamp cell therapy programBiocardia incExchange commissionGlobenewswire incCenters for medicareMaryland stem cell research fundMedical device agencyFailure trialChief executiveCell therapy

BioCardia : Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes - Form 8-K -December 18, 2023 at 07:02 am EST

BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes SUNNYVALE, Calif. - December.

United statesPeter altmanMiranda petoDavid mcclungDevice agency consultation minutesMedicaid servicesExchange commission onBiocardia incDevice agencyCardiamp cell therapy programMaryland stem cell research fundCenters for medicareBiocardia announces expectedFailure japan approval timeline basedMedical device agency consultationJapan pharmaceutical

BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval

BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanBiocardia cardiMiranda petoDavid mcclungExchange commission onBiocardia incCenters for medicareDevice agencyCardiamp cell therapy programMedicaid servicesMaryland stem cell research fundCardia shares updateCell therapyIschemic heart failureForeign data expected